120 related articles for article (PubMed ID: 2731483)
1. Effect of bile salts on the plasma concentration of immunoreactive vasoactive intestinal polypeptide in man.
Matsumura M; Saito S
Endocrinol Jpn; 1989 Feb; 36(1):15-21. PubMed ID: 2731483
[TBL] [Abstract][Full Text] [Related]
2. Effects of bile salts on plasma concentration of beta-endorphin-like immunoreactivity in men.
Matsumura M; Shimizu I; Ohura M; Mori H; Saito S
Dig Dis Sci; 1988 Jun; 33(6):692-6. PubMed ID: 2967167
[TBL] [Abstract][Full Text] [Related]
3. Gastric and intestinal release of vasoactive intestinal polypeptide in the milk-fed lamb.
Reid AM; Shulkes A; Titchen DA
Regul Pept; 1985 Sep; 12(1):43-50. PubMed ID: 4070686
[TBL] [Abstract][Full Text] [Related]
4. Plasma secretin in response to pure bile salts and endogenous bile in man.
Bondesen S; Christensen H; Lindorff-Larsen K; Schaffalitzky de Muckadell OB
Dig Dis Sci; 1985 May; 30(5):440-4. PubMed ID: 3987477
[TBL] [Abstract][Full Text] [Related]
5. Immunoreactive secretin release following taurocholate perfusions of the cat duodenum.
Hanssen LE; Hotz J; Hartmann W; Nehls W; Goebell H
Scand J Gastroenterol; 1980; 15(1):89-95. PubMed ID: 7367827
[TBL] [Abstract][Full Text] [Related]
6. Radioimmunoassay of vasoactive intestinal polypeptide (VIP) in plasma.
Fahrenkrug J; Schaffalitzky de Muckadell OV
J Lab Clin Med; 1977 Jun; 89(6):1379-88. PubMed ID: 325156
[TBL] [Abstract][Full Text] [Related]
7. Evidence of local mechanism involvement in vasoactive intestinal polypeptide release from canine small intestine.
Chijiiwa Y; Misawa T; Ibayashi H
Gastroenterology; 1986 Jun; 90(6):1877-81. PubMed ID: 2870952
[TBL] [Abstract][Full Text] [Related]
8. Release of VIP, secretin and motilin after duodenal acidification in man.
Bloom SR; Mitchell SJ; Greenberg GR; Christofides N; Domschke W; Domschke S; Mitznegg P; Demling L
Acta Hepatogastroenterol (Stuttg); 1978 Oct; 25(5):365-8. PubMed ID: 726803
[TBL] [Abstract][Full Text] [Related]
9. Effect of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide on pancreatic, hepatic and duodenal mucosal bicarbonate secretion in the pig.
Glad H; Ainsworth MA; Svendsen P; Fahrenkrug J; Schaffalitzky de Muckadell OB
Digestion; 2003; 67(1-2):56-66. PubMed ID: 12743442
[TBL] [Abstract][Full Text] [Related]
10. Effect of intraduodenal bile and taurodeoxycholate on exocrine pancreatic secretion and on plasma levels of vasoactive intestinal polypeptide and somatostatin in man.
Riepl RL; Fiedler F; Teufel J; Lehnert P
Pancreas; 1994 Jan; 9(1):109-16. PubMed ID: 7509061
[TBL] [Abstract][Full Text] [Related]
11. Effects of ursodeoxycholate and other bile salts on levels of rat intestinal alkaline sphingomyelinase: a potential implication in tumorigenesis.
Duan RD; Cheng Y; Tauschel HD; Nilsson A
Dig Dis Sci; 1998 Jan; 43(1):26-32. PubMed ID: 9508530
[TBL] [Abstract][Full Text] [Related]
12. Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health.
Dilger K; Hohenester S; Winkler-Budenhofer U; Bastiaansen BA; Schaap FG; Rust C; Beuers U
J Hepatol; 2012 Jul; 57(1):133-40. PubMed ID: 22414767
[TBL] [Abstract][Full Text] [Related]
13. Radioimmunoassay of vasoactive intestinal polypeptide in plasma.
Burhol PG; Lygren I; Waldum HL
Scand J Gastroenterol; 1978; 13(7):807-13. PubMed ID: 725503
[TBL] [Abstract][Full Text] [Related]
14. Effect of fluoxetine on depression-induced changes in the expression of vasoactive intestinal polypeptide and corticotrophin releasing factor in rat duodenum.
Huang YL; Yu JP; Wang GH; Chen ZH; Wang Q; Xiao L
World J Gastroenterol; 2007 Dec; 13(45):6060-5. PubMed ID: 18023100
[TBL] [Abstract][Full Text] [Related]
15. Vasoactive intestinal polypeptide (VIP) in children with neural crest tumours.
Scheibel E; Rechnitzer C; Fahrenkrug J; Hertz H
Acta Paediatr Scand; 1982 Sep; 71(5):721-5. PubMed ID: 6295059
[TBL] [Abstract][Full Text] [Related]
16. Human colonic adenylate cyclase: effects of bile acids.
Simon B; Cyzgan P; Stiehl A; Kather H
Eur J Clin Invest; 1978 Oct; 8(5):321-3. PubMed ID: 103725
[TBL] [Abstract][Full Text] [Related]
17. Effects of solution of low pH and taurocholate on release of beta-endorphin-like immunoreactivity from human duodenal mucosa in vitro.
Matsumura M; Saito S; Fujino M
Regul Pept; 1982 Mar; 3(3-4):173-81. PubMed ID: 6281854
[TBL] [Abstract][Full Text] [Related]
18. Release of oxytocin and vasopressin by intracerebroventricular vasoactive intestinal polypeptide.
Bardrum B; Ottesen B; Fahrenkrug J; Fuchs AR
Endocrinology; 1988 Nov; 123(5):2249-54. PubMed ID: 3168920
[TBL] [Abstract][Full Text] [Related]
19. Localization and release of immunoreactive vasoactive intestinal polypeptide in bovine adrenal medulla.
Yoshikawa M; Saito H; Sano T; Ohuchi T; Ishimura Y; Morita K; Saito S; Oka M
Neurosci Lett; 1990 Mar; 111(1-2):75-9. PubMed ID: 2336195
[TBL] [Abstract][Full Text] [Related]
20. Effects of ursodeoxycholic acid and chenodeoxycholic acid on human hepatocytes in primary culture.
Hillaire S; Ballet F; Franco D; Setchell KD; Poupon R
Hepatology; 1995 Jul; 22(1):82-7. PubMed ID: 7601437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
